Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 213
APPENDIX B
Statement of Task
Major Unit: Institute of Medicine
Division, Office, or Board: Medical Follow-Up Agency
Subject: Strategies to Protect the Health of Deployed U.S. Forces, Subtask 2.4
Staff Officer Name: Lois Joellenbeck
Statement of Task: The project will advise DoD tU.S. Department of Defense]
on a long-term strategy for protecting the health of our nation's military person-
nel when deployed to unfamiliar environments. Drawing on the lessons of pre-
vious conflicts, it will advise the DoD with regard to a strategy for managing the
health and exposure issues faced during deployments; these include infectious
agents, vaccines, drug interactions, and stress. It also will include adverse reac-
tions to chemical or biological warfare agents and other substances. The project
will address the problem of limited and variable data in the past, and in the de-
velopment of a prospective strategy for improved handling of health and expo-
sure issues in future deployments.
Subtask 2.4 concerns medical protection, health consequences and treatment,
and medical record keeping. Specific issues to be addressed include:
. Prevention of adverse health outcomes that could result from exposures to
threats and risks including chemical warfare and biological warfare, infectious
disease, psychological stress, heat and cold injuries, unintentional injuries;
. Requirements for compliance with active duty retention standards;
. Pre-deployment screening, physical evaluation, risk education for troops
and medical personnel;
. Vaccine and other prophylactic agents;
213
OCR for page 213
214 STRATEGIESTOPROTECTTHEHEALTHOFDEPLOYED U.S. FORCES
. Improvements in risk communication with military personnel in order to
minimize stress casualties among exposed, or potentially exposed personnel;
Improvements in the reintegration of all troops to the home environment;
. Treatment of the health consequences of prevention failures, including
battle injuries, DNBI "disease and non-battle injury], acute management, and
long term follow-up;
. Surveillance for short- and long-term outcomes, to include adverse repro-
ductive outcomes; and
. Improvement in keeping medical records, perhaps using entirely new
technology, in documenting exposures, treatment, tracking of individuals
through the medical evacuation system, and health/administrative outcomes.
Sponsorts): Department of Defense
Date of Statement: 11/21/97